Rexahn Pharmaceuticals Inc (REXN)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -40.598 | -102.55 | -64.826 | -59.527 | -160.647 | -259.115 | 47.657 | -19.402 |
| Return on Equity (%) | -51.945 | -149.555 | -105.144 | -84.158 | 1403.249 | -1295.1 | 52.257 | -20.773 |
| Return on Invested Capital (%) | -91.765 | -102.799 | -150.627 | -109.607 | 1129.731 | -518.675 | 52.325 | -21.998 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | -9624.958 | 45.701 | -45.388 |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | -9625.297 | 44.888 | -52.423 |
| Book Value Per Share | 0.072 | 0.529 | 0.281 | 2.478 | -1.238 | 1.179 | 2.217 | 2.205 |
| Earnings Per Share | -0.039 | -0.797 | -0.383 | -2.149 | -2.262 | -3.008 | 0.857 | -0.441 |
| Cash Per Share | 0.049 | 0.281 | 0.233 | 2.294 | 1.507 | 1.302 | 2.044 | 2.231 |
| Working Capital Per Share | 0.08 | 0.785 | 0.34 | 2.428 | 1.331 | 1.179 | 2.216 | 2.205 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | 0.031 | 1.91 | 0.841 |
| EBIT Per Share | -0.039 | -0.797 | -0.383 | -2.149 | -2.262 | -3.008 | 0.873 | -0.441 |
| EBITDA Per Share | -0.039 | -0.797 | -0.383 | -2.149 | -2.262 | -3.008 | 0.873 | -0.441 |
| Free Cash Flow Per Share | -0.039 | -0.796 | -0.383 | -2.146 | -2.263 | -3.008 | 0.857 | -0.441 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.112 | 8.7 | 5.043 | 4.359 | 5.547 | 6.762 | 17.794 | 13.347 |
| Quick Ratio | 10.789 | 8.297 | 4.67 | 4.206 | 5.149 | 6.421 | 15.976 | 12.727 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 237.37M | 31.73M | 37.53M | 4.02M | 10.88M | 18.85M | 20.86M | N/A |
| Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 20.1M | 20.8M | 20.86M | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | -331.103 | N/A | N/A | N/A | -415.313 |
| Net Profit Margin (%) | N/A | N/A | N/A | -331.103 | N/A | N/A | N/A | -415.313 |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | 10.929 | N/A | N/A | N/A | 8.959 |
| Quick Ratio | N/A | N/A | N/A | 10.073 | N/A | N/A | N/A | 8.483 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 40.97M |
| Price to Earnings Ratio | -4.1 |
| Price to Sales Ratio | 2.15 |
| Price to Cash Ratio | 0.81 |
| Price to Book Ratio | 0.82 |
| Dividend Yield | - |
| Shares Outstanding | 22.64M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
